SCHEMBL12830003

SCHEMBL12830003

O=C(NCc1ccccc1)Nc1csc(-c2ccc(Cl)cc2)c1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 4/20 0.49
MDM2 Q00987 4/20 0.49
ALDH1A1 P00352 4/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
MAPT P10636 1/20 0.49
CFD P00746 1/20 0.49
ROCK2 O75116 3/20 0.45
ROCK1 Q13464 3/20 0.45
KDM4E B2RXH2 3/20 0.45
GSK3B P49841 1/20 0.45
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C19 P33261 1/20 0.44
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
IKBKB O14920 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12830007 0.89 CNR1 (0.57) MEN1KMT2AMAPTROCK2ROCK1
SCHEMBL12756641 0.88 IDO1 (0.50) TP53MDM2ALDH1A1MEN1KMT2A
SCHEMBL12830004 0.86 ROCK2 (0.46) ALDH1A1MEN1KMT2AMAPTROCK2
SCHEMBL12756632 0.83 LMNA (0.50) ALDH1A1MEN1KMT2AKDM4ELMNA
SCHEMBL12756682 0.82 PPARG (0.41) TP53MDM2ALDH1A1MEN1KMT2A
SCHEMBL1491014 0.81 HDAC3 (0.50) MEN1KMT2AMAPTCYP1A2CYP2D6
SCHEMBL1490241 0.81 ALOX15 (0.53) MEN1KMT2AMAPTLMNA
SCHEMBL1493891 0.81 ANO1 (0.39) TP53MDM2ALDH1A1MEN1KMT2A
SCHEMBL12756673 0.81 MEN1 (0.44) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL12756631 0.80 NPY5R (0.51) ALDH1A1MEN1KMT2APOLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 US disclosed
WO-2011034962-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2011-03-24 WO disclosed
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2011-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 TP53 2681/4885MDM2 3444/4885ALDH1A1 4409/4885
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 TP53 2681/4885MDM2 3444/4885ALDH1A1 4409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.